Innate Pharma SA (IPHA) Return on equity
Innate Pharma SA (IPHA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to IPHASource: SEC XBRL filings · For reference only · Not investment advice
More IPHA financial trends
IPHA RevenueIPHA Net incomeIPHA Net marginIPHA Gross profitIPHA Gross marginIPHA Operating incomeIPHA Operating marginIPHA Operating cash flowIPHA Free cash flowIPHA Capital expendituresIPHA Stock buybacksIPHA Dividends paidIPHA Total assetsIPHA Total liabilitiesIPHA Shareholders’ equityIPHA overview →